Semaglutide (Ozempic for diabetes, Wegovy for weight loss) represents the most effective pure GLP-1 agonist currently available
However, the dosing and pharmacokinetics are designed so that both receptors receive clinically meaningful activation
There are no doctors, labs, dose adjustments, or safety monitoring, which matters for people who want guidance and accountability
GLP-1 medications do not selectively target abdominal fat but promote generalised weight loss through appetite suppression and reduced caloric intake
MEDVi Pricing Structure, Costs, and Payment Considerations Understanding pricing, payment responsibilities, and safety considerations is essential for individuals evaluating compounded GLP-1 weight loss programs
N Engl J Med (2021) 384(12):111324